Achieve Life Sciences, Inc (ACHV) insider trading
Every open-market stock purchase and sale by Achieve Life Sciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Richard Alistair Stewart (Insider) sold $175K in the last 90 days.
- Last insider buy: Mark K Oki (CFO), $28.9K, 19 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $175K (1 sale). Last close $6.50 on Oct 22, 2026.
Recent ACHV insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 5, 2026 | Benjamin Halladay (CFO) | Bought (not open market) | — |
| Aug 19, 2026 | Richard Alistair Stewart (Insider) | Sold | $175K |
| Jul 27, 2026 | Christopher Nathan Martin (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Christopher Nathan Martin (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Thomas Sellig (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Thomas Sellig (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Aaron Royston (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Aaron Royston (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Reid Alexander Waldman (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Reid Alexander Waldman (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Richard Alistair Stewart (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Richard Alistair Stewart (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Jeffrey S Farrow (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Jeffrey S Farrow (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Nancy R. Phelan (Insider) | Bought (not open market) | — |
| Jul 27, 2026 | Nancy R. Phelan (Insider) | Bought (not open market) | — |
| May 29, 2026 | Jeffrey S Farrow (Insider) | Bought (not open market) | — |
| May 29, 2026 | Reid Alexander Waldman (Insider) | Bought (not open market) | — |
| May 11, 2026 | Christopher Nathan Martin (Insider) | Bought (not open market) | — |
| Apr 18, 2026 | Andrew D. Goldberg (CEO) | Bought (not open market) | — |
| Apr 18, 2026 | Andrew D. Goldberg (CEO) | Bought (not open market) | — |
| Apr 18, 2026 | Andrew D. Goldberg (CEO) | Bought (not open market) | — |
| Jan 28, 2026 | Mark Lawrence Rubinstein (C-suite exec) | Bought (not open market) | — |
| Jan 28, 2026 | Richard Alistair Stewart (CEO) | Bought (not open market) | — |
| Jan 28, 2026 | Jerry Wan (Insider) | Bought (not open market) | — |
Who's trading ACHV
- Benjamin Halladay, CFO: other filings, last Oct 5, 2026
- Richard Alistair Stewart, CEO: sold $175K (1 sale), last Aug 19, 2026
- Reid Alexander Waldman, Insider: other filings, last Jul 27, 2026
- Jeffrey S Farrow, Insider: other filings, last Jul 27, 2026
- Thomas Sellig, Insider: other filings, last Jul 27, 2026
- Aaron Royston, Insider: other filings, last Jul 27, 2026
- Christopher Nathan Martin, Insider: other filings, last Jul 27, 2026
- Nancy R. Phelan, Insider: other filings, last Jul 27, 2026
- Andrew D. Goldberg, CEO: other filings, last Apr 18, 2026
- Jaime Xinos, C-suite exec: other filings, last Jan 28, 2026
- Craig Donnelly, C-suite exec: other filings, last Jan 28, 2026
- Mark K Oki, CFO: other filings, last Jan 28, 2026
- Mark Lawrence Rubinstein, C-suite exec: other filings, last Jan 28, 2026
- Jerry Wan, Insider: other filings, last Jan 28, 2026
- Erik Atkisson, C-suite exec: other filings, last Dec 4, 2025
Get free alerts when an insider at Achieve Life Sciences, Inc files a new trade →